GSA Capital Partners LLP Acquires New Stake in Integral Ad Science Holding Corp. (NASDAQ:IAS)

Key Points

• GSA Capital Partners LLP acquired 74,787 shares of Integral Ad Science Holding Corp., valued at approximately $603,000, as reported in a recent SEC filing.
• Several hedge funds, including Raymond James Financial and Vanguard Group, have also increased their stakes in Integral Ad Science, indicating strong institutional interest.
• Integral Ad Science's CEO, Lisa Utzschneider, recently sold 14,904 shares, representing a 3.78% decrease in her ownership, while insiders have sold a total of 33,518 shares over the last three months.

GSA Capital Partners LLP bought a new stake in shares of Integral Ad Science Holding Corp. (NASDAQ:IAS - Free Report) during the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor bought 74,787 shares of the company's stock, valued at approximately $603,000.

Several other large investors also recently modified their holdings of IAS. Vanguard Group Inc. grew its stake in Integral Ad Science by 2.3% in the fourth quarter. Vanguard Group Inc. now owns 9,048,546 shares of the company's stock worth $94,467,000 after purchasing an additional 205,562 shares in the last quarter. Alyeska Investment Group L.P. acquired a new stake in shares of Integral Ad Science in the fourth quarter valued at about $41,543,000. Dimensional Fund Advisors LP raised its position in shares of Integral Ad Science by 18.1% during the 4th quarter. Dimensional Fund Advisors LP now owns 3,789,996 shares of the company's stock valued at $39,567,000 after buying an additional 580,323 shares during the period. Ararat Capital Management LP increased its position in shares of Integral Ad Science by 13.4% during the fourth quarter. Ararat Capital Management LP now owns 2,281,912 shares of the company's stock valued at $23,823,000 after acquiring an additional 269,346 shares during the last quarter. Finally, Nuveen Asset Management LLC grew its stake in shares of Integral Ad Science by 0.8% in the fourth quarter. Nuveen Asset Management LLC now owns 1,920,523 shares of the company's stock worth $20,050,000 after acquiring an additional 15,432 shares in the last quarter. Institutional investors own 95.78% of the company's stock.

Insiders Place Their Bets

In related news, CEO Lisa Utzschneider sold 14,904 shares of Integral Ad Science stock in a transaction dated Tuesday, July 8th. The stock was sold at an average price of $8.31, for a total value of $123,852.24. Following the sale, the chief executive officer directly owned 379,316 shares in the company, valued at approximately $3,152,115.96. The trade was a 3.78% decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. In the last 90 days, insiders have sold 25,151 shares of company stock valued at $209,075. 2.00% of the stock is currently owned by corporate insiders.

Integral Ad Science Trading Down 3.2%

Shares of NASDAQ:IAS traded down $0.26 during midday trading on Thursday, hitting $7.82. 646,922 shares of the stock were exchanged, compared to its average volume of 1,020,493. Integral Ad Science Holding Corp. has a 12 month low of $6.26 and a 12 month high of $13.62. The company has a debt-to-equity ratio of 0.01, a quick ratio of 4.01 and a current ratio of 4.01. The business's 50-day moving average price is $8.19 and its 200 day moving average price is $8.56. The stock has a market capitalization of $1.29 billion, a price-to-earnings ratio of 26.88, a P/E/G ratio of 1.37 and a beta of 1.57.

Integral Ad Science (NASDAQ:IAS - Get Free Report) last issued its earnings results on Monday, May 12th. The company reported $0.05 EPS for the quarter, topping the consensus estimate of $0.03 by $0.02. The business had revenue of $134.07 million during the quarter, compared to the consensus estimate of $129.20 million. Integral Ad Science had a return on equity of 4.74% and a net margin of 8.56%. Analysts predict that Integral Ad Science Holding Corp. will post 0.26 earnings per share for the current year.

Analysts Set New Price Targets

Several equities analysts have weighed in on IAS shares. Stifel Nicolaus raised their target price on shares of Integral Ad Science from $13.00 to $14.00 and gave the company a "buy" rating in a report on Tuesday, July 22nd. Raymond James Financial raised their price objective on shares of Integral Ad Science from $11.00 to $13.00 and gave the company an "outperform" rating in a research report on Tuesday, May 13th. Wall Street Zen cut shares of Integral Ad Science from a "buy" rating to a "hold" rating in a report on Saturday, August 2nd. Morgan Stanley reduced their price objective on shares of Integral Ad Science from $13.50 to $12.50 and set an "equal weight" rating for the company in a research note on Thursday, April 17th. Finally, Barclays upped their target price on shares of Integral Ad Science from $7.00 to $9.00 and gave the company an "equal weight" rating in a research note on Tuesday, May 13th. Seven research analysts have rated the stock with a hold rating and six have issued a buy rating to the company. According to MarketBeat.com, the company currently has a consensus rating of "Hold" and an average target price of $13.65.

Integral Ad Science Company Profile

Integral Ad Science Holding Corp. operates as a digital advertising verification company in the United States, the United Kingdom, France, Ireland, Germany, Italy, Singapore, Australia, Japan, India, and the Nordics. The company provides IAS Signal, a cloud-based technology platform that offers return on ad spend needs; and deliver independent measurement and verification of digital advertising across devices, channels, and formats, including desktop, mobile, connected TV, social, display, and video.